High-performance liquid chromatography method for the quantifi cation of duloxetine in rat plasma
Keywords:
Duloxetine, Trifluoperazine, HPLC, Validation, Rat PlasmaAbstract
A sensitive and selective HPLC method was developed for quantifi cation of duloxetine, in rat plasma. Trifl uoperazinewas used as an internal standard (IS). The present method used protein precipitation for extraction of the drug fromrat plasma. Separation and quantifi cation was carried using in isocratic mode using 25 mM phosphate buffer (pH3.0)/acetonitrile (60:40, % v/v) as mobile phase and on reverse-phase C18 phenyl column (250 mm x 4.6 mm, 5μ) andthe column effl uent was monitored by UV detector at 217 nm. This method was linear over the range of 44 - 2816.00ng/ml with regression coeffi cient greater than 0.99. The mean recovery of duloxetine and IS were 82.33 ± 2.10 and75.37 ± 1.07, respectively and the method was found to be precise, accurate and specifi c during the study. This validatedmethod is sensitive and reproducible and it can be used for pharmacokinetic studies.Downloads
References
Anderson D, Reed S, Lintemoot J, Kegler S, DeQuintana S, and Sandberg M. A fi rst look at duloxetine (Cymbalta) in a postmortem laboratory. J Anal Toxicol 2006: 30; 576-580.
Brunton LL, Parker KS, Lazo JS. In: Goodman and Gillman’s, The pharmacological basis of therapeutics, 11th edn., McGraw Hill Publishing, London 2005: 436-450.
Mercolini L, Mandrioli R, Cazzolla R, Amore M, and Raggi MA. HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure. J Chromatogr B Analyt Technol Biomed Life Sci 2007: 856; 81-87.
Ma N, Zhang BK, Li HD, Chen BM, Xu P, and Wang F. Determination of duloxetine in human plasma via LC/MS and subsequent application to a pharmacokinetic study in healthy Chinese volunteers. Clin Chim Acta 2007: 380; 100-105.
Lobo ED, Loghin C, Knadler MP, Quinlan T, Zhang L, and Chappell J. Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women. Clin Pharmacokinet 2008: 47; 103-109.
Pankaj Soni, Mariappan TT, and Banerjee UC. High performance liquid chromatographic method for the simultaneous estimation of the key intermediates of Duloxetine. Talanta 2005: 67; 975-978.
Satonin DK, McCulloch JD, Kuo F, and Knadler MP. Development and validation of a liquid chromatography-tandem mass spectrometric method for the determination of the major metabolites of duloxetine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2007: 852; 582-589.
Schultz MM, and Furlong ET. Trace Analysis of Antidepressant Pharmaceuticals and Their Select Degradates in Aquatic Matrixes by LC/ESI/MS/MS. Anal Chem 2008: 80; 1756-1762.
Senthamil Selvan P, Gowda KV, Mandal U, Sam Solomon WD, and Pal TK. Determination of duloxetine in human plasma by liquid chromatography with atmospheric pressure ionization-tandem mass spectrometry and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2007: 858; 269-275.
Silva BJ, Lancas FM, and Queiroz ME. In-tube solid-phase microextraction coupled to liquid chromatography (in-tube
SPME/LC) analysis of nontricyclic antidepressants in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2008: 862; 181-188.
Sweetman SC. In: Martindale, The complete drug reference, 34th Edn., Pharmaceutical Press, Great Britain, 2005: 291.
Waldschmitt C, Vogel F, Maurer C, and Hiemke C. Measurement of duloxetine in blood using high-performance liquid chromatography with spectrophotometric detection and column switching. Ther Drug Monit 2007: 29; 767-772.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).